IVIG in Painful Sensory Neuropathy

The goal of this clinical trial is to assess effect of Intravenous immunoglobulins (antibodies) as compared to Placebo, on pain intensity in patients from 18-65 years with painful sensory neuropathy without a known cause. Effect of the treatment will be recorded by the patient in a digital diary.

NCT Number	NCT06183008
Lead Sponsor	Sorlandet Hospital HF Collaborators: Oslo University Hospital, University Hospital of North Norway, University Hospital of Saint-Etienne
Conditions	Sensory Neuropathy, Small Fiber Neuropathy
Enrollment	20 participants
Start Date	2024-02
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2023-12-27